Fine Pharma Pack Llp Profile
Key Indicators
- Obligation of Contribution ₹ 10.00 Cr
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 55.31 Cr
About Fine Pharma Pack Llp
Fine Pharma Pack Llp (FPPL) is 4 Year, 6 Months old Limited Liability Partnership 28 July 2020. Its registered office is in Solan, Himachal Pradesh, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 10.00 Cr as per MCA.
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAT-1125
- Incorporation Date
28 Jul 2020
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Himachalpradesh
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Fine Pharma Pack Llp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxmi Shetty  | Designated Partner | 28-Jul-2020 | Current |
| Nishank Sakariya | Designated Partner | 07-Oct-2021 | Current |
| Prabha Srisrimal | Designated Partner | 28-Jul-2020 | Current |
Financial Performance of Fine Pharma Pack Llp.
Enhance accessibility to Fine Pharma Pack Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Fine Pharma Pack Llp?
Unlock access to Fine Pharma Pack Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Megh Promoters Private LimitedNishank Sakariya is a mutual person
Bhavani Seals Private LimitedLaxmi Shetty is a mutual person
Narendra Properties LimitedNishank Sakariya is a mutual person
Ghack Technologies Private LimitedNishank Sakariya is a mutual person
Maxx Farmacia (India) LlpPrabha Srisrimal is a mutual person
Fineflexo LlpLaxmi Shetty and Prabha Srisrimal are mutual person
Charges (Loans)
₹55.31 Cr
₹0
Charges Breakdown by Lending Institutions
- The Hongkong And Shanghai Banking Corporation Limited : 55.31 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹55.31 Cr | Open |
How Many Employees Work at Fine Pharma Pack Llp?
Unlock and access historical data on people associated with Fine Pharma Pack Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fine Pharma Pack Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fine Pharma Pack Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.